- Report
- January 2022
- 132 Pages
Global
From €4621EUR$4,799USD£3,975GBP
- Report
- October 2022
- 338 Pages
Europe, Global, Asia Pacific Europe, Global, Asia Pacific
From €4621EUR$4,799USD£3,975GBP
- Report
- February 2020
- 304 Pages
Global
From €4718EUR$4,899USD£4,057GBP
From €4093EUR$4,250USD£3,520GBP
- Report
- January 2022
- 148 Pages
Global
From €4093EUR$4,250USD£3,520GBP
From €400EUR$445USD£356GBP
- Report
- February 2023
- 340 Pages
Global
From €4754EUR$5,109USD£3,950GBP
- Report
- February 2022
- 800 Pages
Global
From €3467EUR$3,600USD£2,982GBP
- Report
- July 2020
- 1200 Pages
Japan
From €2889EUR$3,000USD£2,485GBP
- Drug Pipelines
- February 2018
- 440 Pages
Global
From €2311EUR$2,400USD£1,988GBP
- Clinical Trials
- February 2018
- 225 Pages
Global
From €2311EUR$2,400USD£1,988GBP
- Report
- February 2018
- 160 Pages
Global
From €2119EUR$2,200USD£1,822GBP
- Report
- May 2019
- 115 Pages
Global
From €602EUR$625USD£518GBP
€1204EUR$1,250USD£1,035GBP
- Report
- November 2022
- 260 Pages
Global
From €4754EUR$5,109USD£3,950GBP
- Report
- July 2022
- 163 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
- Report
- May 2022
- 151 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
- Report
- August 2022
- 99 Pages
North America
From €2022EUR$2,100USD£1,739GBP
€2889EUR$3,000USD£2,485GBP
- Report
- August 2019
- 152 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
- Report
- February 2024
- 80 Pages
Japan
From €4574EUR$4,750USD£3,934GBP
- Report
- April 2023
- 350 Pages
Global
From €3130EUR$3,250USD£2,692GBP
The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient.
The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more